Browsing by Author Farrar, Michelle

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2017Burning pain: axonal dysfunction in erythromelalgiaHowells, James Anthony; Andrews, P. Ian; Farrar, Michelle; Lee, Ming-Jen; Lin, Cindy S.-Y; Central Clinical School: OfficeBurning pain: axonal dysfunction in erythromelalgia, Pain, vol.158, 5, 2017,pp 900-911
2016Clinical Characteristics and Functional Motor Outcomes of Enterovirus 71 Neurological Disease in ChildrenBooy, Robert; Britton, Philip; Dale, Russell; Jones, Cheryl; Mohammad, Shekeeb; Andrews, P Ian; Farrar, Michelle; Kandula, Tejaswi; Lorentzos, Michelle S; Ramachandran, Vidiya; Rawlinson, William; Rodriguez, Michael; Sampaio, Hugo; Teoh, Hooi-Ling; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Childrens Medical Research InsClinical Characteristics and Functional Motor Outcomes of Enterovirus 71 Neurological Disease in Children, JAMA Neurology, vol.73, 3, 2016,pp 300-307
2012Corticomotoneuronal Integrity and Adaptation in Spinal Muscular AtrophyVucic, Ostoja (Steve); Farrar, Michelle; Johnston, Heather; Kiernan, Matthew C; Western Clinical School: Medicine (Westmead)Corticomotoneuronal Integrity and Adaptation in Spinal Muscular Atrophy, Archives of Neurology, vol.69, 4, 2012,pp 467-473
2015The Genetics of Spinal Muscular Atrophy: Progress and ChallengesKiernan, Matthew; Farrar, Michelle; Central Clinical School: MedicineThe Genetics of Spinal Muscular Atrophy: Progress and Challenges, Neurotherapeutics, vol.12, 2, 2015,pp 290-302
2013Identification of KLHL41 Mutations Implicates BTB-Kelch-Mediated Ubiquitination as an Alternate Pathway to Myofibrillar Disruption in Nemaline MyopathyClarke, Nigel; Sandaradura, Sarah; Darras, B T; et al, Various; Farrar, Michelle; Gupta, Vandana; Hsu, Cynthia; Ogata, Kazuhiro; Ravenscroft, Gianina; Shaheen, Ranad; Shiina, Masaaki; Swanson, Lindsay; Todd, Emily; Children's Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Paediatrics & Child HealthIdentification of KLHL41 Mutations Implicates BTB-Kelch-Mediated Ubiquitination as an Alternate Pathway to Myofibrillar Disruption in Nemaline Myopathy, American Journal of Human Genetics, vol.93, 6, 2013,pp 1108-1117
2017Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancerBoyle, Frances; Grimison, Peter; Horvath, Lisa; Kiernan, Matthew; Park, Susanna; Baron-Hay, S; Farrar, Michelle; Goldstein, David; Kandula, Tejaswi; Krishnan, Arun V.; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Medical Sciences: PhysiologyNeurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer, Clinical Neurophysiology, vol.128, 7, 2017,pp 1166-1175
2016Neurophysiological profile of peripheral neuropathy associated with childhood mitochondrial diseaseBhattacharya, Kaustuv; Christodoulou, John; Ellaway, Carolyn; Menezes, Manoj; Ouvrier, Robert; Clark, Damian; Farrar, Michelle; Pitt, Matthew; Rahman, Shamima; Ryan, Monique; Sampaio, Hugo; Thorburn, David; Ware, Tyson L; Wedatilake, Yehani; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child Health; Clinical and Rehabilitation Sciences; Childrens Hospital Westmead: Paediatrics & Child HealthNeurophysiological profile of peripheral neuropathy associated with childhood mitochondrial disease, Mitochondrion, vol.30, N/A, 2016,pp 162-167
2016Novel motor phenotypes in patients with VRK1 mutations without pontocerebellar hypoplasiaNicholson, Garth; Buckley, Michael F.; Farrar, Michelle; Lee, James; Reddel, Stephen; Roscioli, Tony; Sampaio, Hugo; Stoll, Marion; Teoh, Hooiling; Zhu, Ying; Concord Clinical School: ANZAC Research InstituteNovel motor phenotypes in patients with VRK1 mutations without pontocerebellar hypoplasia, Neurology, vol.87, 1, 2016,pp 65-70
2013Pathophysiological Insights Derived by Natural History and Motor Function of Spinal Muscular AtrophyVucic, Steve; du Sart, Desiree; Farrar, Michelle; Johnston, Heather; Kiernan, Matthew C; Western Clinical School: Medicine (Westmead)Pathophysiological Insights Derived by Natural History and Motor Function of Spinal Muscular Atrophy, The Journal of Pediatrics, vol.162, 1, 2013,pp 155-159
2016Pathophysiology of motor dysfunction in a childhood motor neuron disease caused by mutations in the riboflavin transporterBurns, Joshua; Kiernan, Matthew; Menezes, Manoj; Ouvrier, Robert; Vucic, Steve; Antony, Jayne; Farrar, Michelle; O'Brien, Katie; Webster, Richard; Clinical and Rehabilitation Sciences; Central Clinical School: Medicine; Clinical and Rehabilitation Sciences; Childrens Hospital Westmead: Paediatrics & Child Health; Western Clinical School: Medicine (Westmead)Pathophysiology of motor dysfunction in a childhood motor neuron disease caused by mutations in the riboflavin transporter, Clinical Neurophysiology, vol.127, 1, 2016,pp 911-918
2017Safety and efficacy of progressive resistance exercise for Charcot-Marie-Tooth disease in children: a randomised, double-blind, sham-controlled trialBurns, Joshua; Cornett, Kayla; Mandarakas, Melissa; Menezes, Manoj; Raymond, Jacqueline; Refshauge, Kathryn; Rose, Kristy Joy; Sman, Amy; Wojciechowski, Elizabeth; Bray, Paula; Farrar, Michelle; Sampaio, Hugo; Walker, Terri; Clinical and Rehabilitation Sciences; Physiotherapy; Clinical and Rehabilitation Sciences; Clinical and Rehabilitation Sciences; Exercise Health and Performance; Clinical and Rehabilitation Sciences; Clinical and Rehabilitation Sciences; Clinical and Rehabilitation Sciences; Health SciencesSafety and efficacy of progressive resistance exercise for Charcot-Marie-Tooth disease in children: a randomised, double-blind, sham-controlled trial, The Lancet Child & Adolescent Health, vol.1, 2, 2017,pp 106-113